The Health Impact Fund: making the case for engagement with pharmaceutical laboratories in Brazil, Russia, India, and China
Abstract Despite progress in global health, the general disease burden still disproportionately falls on low- and middle-income countries. The health needs of these countries’ populations are unmet because there is a shortage in drug research and development, as well as a lack of access to essential...
Autores principales: | , , |
---|---|
Formato: | Artículo |
Lenguaje: | English |
Publicado: |
BMC
2021-09-01
|
Colección: | Globalization and Health |
Materias: | |
Acceso en línea: | https://doi.org/10.1186/s12992-021-00744-x |